LFMD
Get informed when a big investor buys or sells
+ Follow| Market cap | $160.08 Million |
|---|---|
| Enterprise Value | $151.75 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.23 |
| Beta | 2.06 |
| Outstanding Shares | 47,788,194 |
| P/E Ratio | -6.52 |
|---|---|
| PEG | -2.7 |
| Price to Sales | 1.09 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.01 |
| Enterprise Value to EBIT | -5.99 |
| Enterprise Value to Net Income | -113 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 2.11 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.6964▲ 1.99% |
|---|---|
| Total Calls | 802,000▲ 166.36% |
| Total Puts | 558,500▲ 174.18% |
Holdings and activity of institutional investors.
| Ownership % | 45.93%▲ 7.80% |
|---|---|
| Total Invested | $89.78M▲ 39.46% |
| Investors Holding | 122▲ 15.00% |
No data
LifeMD, Inc. (formerly Conversion Labs) is a leading telehealth company that is transforming the healthcare landscape with direct-to-patient product and service offerings. LifeMD's telemedicine platform enables virtual access to affordab...